Skip to main content
Top
Published in: Diabetology & Metabolic Syndrome 1/2015

Open Access 01-12-2015 | Meeting abstract

Risk factors for ulceration and amputation in patients with diabetic foot at risk: results form a tertiary care center

Authors: Adriana Russo Fiore, Arnaldo Moura Neto, Karla Borges Daniel, Walter José Minicucci, Denise Engelbrecht Zantut Wittmann, Marcos Antonio Tambascia, Elizabeth João Pavin, Maria Cândida Ribeiro Parisi

Published in: Diabetology & Metabolic Syndrome | Special Issue 1/2015

Login to get access

Excerpt

Ulceration and amputation are severe complications of diabetes, leading to great morbidity and mortality. Of all lower limb amputations, about 50% are performed in these patients (1). In their lifetime, diabetics have a chance as high as 25% to develop a foot ulcer (2). After an amputation, mortality rates ranges from 13% to 40% at 1 year, 35% to 65% at 3 yrs., and 39% to 80% at 5 yrs. (3). The aim of this study was to assess the main risk factors of ulceration and amputation in patients with type 1 and type 2 diabetes. …
Metadata
Title
Risk factors for ulceration and amputation in patients with diabetic foot at risk: results form a tertiary care center
Authors
Adriana Russo Fiore
Arnaldo Moura Neto
Karla Borges Daniel
Walter José Minicucci
Denise Engelbrecht Zantut Wittmann
Marcos Antonio Tambascia
Elizabeth João Pavin
Maria Cândida Ribeiro Parisi
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Diabetology & Metabolic Syndrome / Issue Special Issue 1/2015
Electronic ISSN: 1758-5996
DOI
https://doi.org/10.1186/1758-5996-7-S1-A18

Other articles of this Special Issue 1/2015

Diabetology & Metabolic Syndrome 1/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine